Skip to content

Clinical trials

Completed Neuralgia trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Status: Completed Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20124
20131
20162
20172
20191
20201
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University3
GL Pharm Tech Corporation2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Catholic University of Korea Saint Paul's Hospital1
Eli Lilly and Company1
Helixmith Co., Ltd.1
IlDong Pharmaceutical Co Ltd1
JMackem Co., Ltd1
Ju Seok Ryu1
Seoul National University Bundang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia17
Diabetic Neuropathies5
Neuralgia, Postherpetic4
Spinal Cord Injuries3
Complex Regional Pain Syndromes1
Diabetes Mellitus, Type 21
Failed Back Surgery Syndrome1
Hypesthesia1
Paresthesia1
Peripheral Nervous System Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.